The presentation will review both continued use of patient technologies during hospitalization and the emerging use of hospital furnished CGM systems.
45-minute ProgramEffective dates for CE credit: 12/14/2024 – 12/14/2025
This presentation discusses the implementation and potential benefits of diabetes technologies including continuous glucose monitoring (CGM) in the inpatient setting, highlighting their impact on patient care and nursing workload. The presentation will review both continued use of patient technologies during hospitalization and the emerging use of hospital furnished CGM systems.
The fourth annual Diabetes Technology Conference goal is to ensure diabetes care and education specialists, nurse practitioners, PAs, physicians, and other healthcare professionals are knowledgeable about the newest diabetes technologies and can effectively implement and utilize them to improve clinical outcomes, enhance patient satisfaction and create a more data-driven diabetes care planning. Each session will highlight technology, providers who prescribe it and use the data to adjust treatment plans and people with diabetes who use the technology firsthand. This technology feedback loop results in collaboration that maximizes efficiency and satisfaction.
This recording of a live presentation is a knowledge-based learning activity.
Enduring Material
This activity is designed for individual or groups of diabetes care and education specialists, including nurses, dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners, clinical nurse specialists, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.
Joint Providership
None
This activity is supported by a grant from the Leona M. and Harry B. Helmsley Charitable Trust.
You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).Originally presented on: 12/14/2024Expiration date: 12/14/2025
Eileen R. Faulds, PhD, CNPAssistant Professor Tenure-trackThe Ohio State University Medical Center/The Ohio State University College of Nursing
In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.
Joint Accreditation/ACCME also requires that ADCES mitigate any reported conflict and eliminate the potential for bias during the educational activity. The disclosure information is intended to identify any ineligible relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:
Speakers
Eileen R. Faulds, PhD, CNP: No relevant disclosure to display
Planners
Paulina N. Duker, MPH, RN, CDCES: No financial relationships to discloseDiana M. Isaacs, PharmD, BCPS, BC-ADM, CDCES: Abbott: Speaker/Honoraria (Ongoing); Dexcom: Speaker/Honoraria (Ongoing); Eli Lilly Pharmaceuticals: Speaker/Honoraria (Ongoing); Insulet: Speaker/Honoraria (Ongoing); MannKind: Speaker/Honoraria (Ongoing); Medtronic: Consultant (Ongoing); Novo Nordisk: Speaker/Honoraria (Ongoing); Tandem: Consultant (Ongoing)Gary Scheiner, MS, CDCES: No relevant disclosure to displayNatalie J. Bellini, DNP, FNP-BC, BC-ADM, CDCES: No relevant disclosure to displaySean M. Oser, MD, MPH, CDCES: No relevant disclosure to displaySara Wettergreen, PharmD, BCACP, BC-ADM: No financial relationships to discloseDavida Kruger, MSN, NP, APRN, BC-ADM: Novo Nordisk, Dexcom, Lilly, Cequr, Xeris, Sanofi: Speakers Bureau; Novo Nordisk, Lilly, Mannkind, Cequr, Abbott, Medtronic, Sanofi: Consultant; Abbott, Insulet, Tandem, Novo Nordisk, Betabionics: Institutional ResearchAmy Butts, PA, BC-ADM, CDCES: Abbott Diabetes: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Speaker/Honoraria (Ongoing); Sanofi: Consultant (Ongoing)Celia Ann Levesque, APRN, NP-C, CNS-BC, CDE, BC-ADM: No financial relationships to discloseAngela Thompson, DNP, APRN, FNP-C, BC-ADM, CDCES, FAANP: Novo Nordisk: ConsultantKristine Batty, BC-ADM, CDCES, PhD, ARNP: No relevant disclosure to displayBecky Sulik, RDN, LD, CDCES: No relevant disclosure to displayCari Berget, RN, MPH, CDCES: Dexcom: Speaker/Honoraria (Ongoing); Insulet: Consultant (Ongoing), Speaker/Honoraria (Ongoing)Linda Parks, MS, RN CDCES: Senseonics, Inc. Glooko, Inc: Stock; Glucotrack, Inc: ConsultantDana Roseman, MPH, RD, RDN: No relevant disclosure to display
All identified relevant conflicts of interest have been mitigated.
The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.
In support of improving patient care, the Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
The Universal Activity Number is JA4008258-0000-24-366-H01-P This knowledge-based activity has been approved for 0.75 contact hour(s).This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.
Association of Diabetes Care & Education Specialists designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Association of Diabetes Care & Education Specialists designates this activity for a maximum of 0.75 ANCC contact hour(s). This activity discusses 0.0 contact hour(s) of pharmacotherapeutic content.The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 0.75 contact hour(s).
The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credit(s). Approval is valid until 12/14/25. PAs should only claim credit commensurate with the extent of their participation.
CDR Credentialed Practitioners will receive 0.75 Continuing Professional Education unit(s) (CPEU) for completion of this activity.Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.
To receive a Statement of Credit you must participate in the full activity and complete an evaluation.
To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.
ADCES is the administering body for the Advanced Diabetes Management credentials. Continuing education programs offered by ADCES can be used toward fulfilling BC-ADM Certification and recertification requirements.
It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.